LONDON--()--Weakness of product pipelines together with the absence of adequate treatment methods for a number of disorders lead to the slight growth of a few markets for inherited orphan blood diseases therapeutics. However, only the hereditary angioedema therapeutics market is relatively given the availability of Cinryze which is currently ruling the market. It is expected to grow at a slow pace (CAGR 3 percent) in the upcoming years to reach USD 1.88 billion by 2020.
“Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need”
The sickle cell anemia market is expected to demonstrate significant growth in the future. It is forecast to amount to USD 69.5 billion by 2020, up by USD 34 billion from 2012.
New market research report “Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need” drawn up by GBI Research offers a 360 degree picture of the market for inherited orphan blood disorders therapeutics, focusing on sickle cell anemia, thalassemia and Hereditary Angioedema. The report provides a detailed review of the seven top markets: the US, France, Germany, Italy, Spain, the UK and Japan. The research study contains valuable data on treatment trends and the most recent industry activities as well as examination of developmental pipelines for the disorders. Market drivers and restraints are described; therapy costs, treatment usage patterns and future market projections are included in the report.
Report Details:
Title: Inherited Orphan Blood Disorders Therapeutics Market to 2019 -
Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Published:
January, 2013
Pages: 81
Price: US$ 3,500.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/inherited-orphan-blood-disorders-therapeutics-market-to-2019-breakthrough-drugs-remain-elusive-against-backdrop-of-high-unmet-need.html
More In-Demand Market Research Reports by GBI Research Include:
- Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products
- Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share
- Vinyl Acetate Monomer (VAM) Global Market to 2020 - Increased demand in Asia Pacific VA-based EVA Photovoltaic Applications to drive growth
More new market research reports by GBI Research can be found at http://marketpublishers.com/members/gbiresearch/info.html
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 